COVID-19: Vaccines and Therapeutics
Data submitted to the Food and Drug Administration confirms that Johnson & Johnson’s COVID-19 vaccine candidate is safe and effective.
The Department of Veterans Affairs’ Community Care Network now offers COVID-19 vaccinations to eligible veterans nationwide at its urgent care and retail pharmacy locations, the agency reports.
Johnson & Johnson plans to deliver 20 million doses of its COVID-19 vaccine candidate to the United States by the end of March if the Food and Drug Administration authorizes emergency use of the single-dose vaccine, a company executive told a House subcommittee at a hearing on expanding vaccine…
Authorized health care providers should now order the monoclonal antibody therapy bamlanivimab and antibody cocktail casirivimab/imdevimab directly from the sole distributor, AmerisourceBergen Corp., the Department of Health and Human Services announced.
New data from Pfizer Inc. indicates that its COVID-19 vaccine is more stable than previously believed when stored -25°C to -15°C (-13°F to 5°F), temperatures more commonly found in pharmaceutical freezers and refrigerators.
President Biden told a group of G-7 leaders that the U.S. will support the COVAX alliance tasked with distributing COVID-19 vaccines to 92 low- and middle-income countries.
The AHA recently launched a new webpage dedicated to disseminating accessible information focused on addressing the equity issues in COVID-19 testing, treatment and vaccine administration efforts.
Safety monitoring during the first month of the COVID-19 national vaccination program shows “reassuring safety profiles” for the Pfizer and Moderna COVID-19 vaccines, the Centers for Disease Control and Prevention reported.
Advancing health equity within communities of color disproportionately impacted by COVID-19 — and getting the facts straight about reasons for hesitancy over receiving vaccines — are priority issues for government policy influencers and health care organization leaders.
With our nation’s COVID-19 vaccine administration rollout underway, policy influencers and advocacy groups are focusing on communities of color that have been disproportionately impacted by the fluctuating pandemic.